Concepedia

Author

Dan Aderka

Tel Aviv University

Also Known As

Abou-Alfa, Aderka, D., D ADERKA, D Aderka, D. Aderka, D. aderka, DAN ADERKA, Dan Aderka, Naama Halpern

195

Publications

12.2K

Citations

36

H-Index

132

Concepts

All Affiliations

Tel Aviv UniversitySheba Medical CenterWeizmann Institute of ScienceTel Aviv Sourasky Medical CenterRabin Medical Center
DA

About

Dan Aderka is an author at Tel Aviv University specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

40

7.4K

2

Health Sciences

7

7

275

3

Public Health

3

3

80

4

Allergy

3

3

80

5

Social Sciences

1

1

39

Dan Aderka

×

63

Publications

10.9K

Citations

32

H-Index

YearCitations

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Eric Van Cutsem, Andrés Cervantes, René Adam,

Annals of Oncology

2016

3.3K

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein,

Annals of Oncology

2012

1.5K

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

Dan Aderka, Hartmut Engelmann, ‪Yasmin Maor‬‏,

The Journal of Experimental Medicine

1992

822

IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Dan Aderka, Junming Le, J Vilček

The Journal of Immunology

1989

576

Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions

Parisa Ettehadi, M.W. Greaves, David Wallach,

Clinical & Experimental Immunology

1994

484

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity

Hartmut Engelmann, Dan Aderka, Menachem Rubinstein,

Journal of Biological Chemistry

1989

440

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

Talia Golan, Zaheer Kanji, Ron Epelbaum,

British Journal of Cancer

2014

428

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

Andrew P. Cope, Deena L. Gibbons, Fionula M. Brennan,

Arthritis & Rheumatism

1992

338

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

Y. Nophar, O. Kemper, Cord Brakebusch,

The EMBO Journal

1990

332

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.

Dan Aderka, Vered Hornik, Yehuda Skornick,

PubMed

1991

239

Page 1